DMD

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on May 12, 2008; DOI: 10.1124/dmd.108.021592


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.108.021592v1
36/8/1578    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lu, T.
Right arrow Articles by Li, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lu, T.
Right arrow Articles by Li, C.


Received for publication March 27, 2008.
Revised May 7, 2008.
Accepted for publication May 9, 2008.

Plasma and Urinary Tanshinol from Salvia Miltiorrhiza (Danshen), Can Be Used as Pharmacokinetic Markers for Cardiotonic Pills, a Cardiovascular Herbal Medicine

Tong Lu 1, Junling Yang 1, Xiumei Gao 2, Ping Chen 1, Feifei Du 1, Yan Sun 1, Fengqing Wang 1, Fang Xu 1, Hongcai Shang 2, Yuhong Huang 2, Yi wang 2, Renzhong Wan 3, Changxiao Liu 3, Boli Zhang 2, Chuan Li 1*

1 Shanghai Institute of Materia Medica 2 Tianjin University of Traditional Chinese Medicine 3 Tianjin Institute of Pharmaceutical Research

* Address correspondence to: E-mail: chli{at}mail.shcnc.ac.cn

Abstract

Cardiotonic pills are a type of cardiovascular herbal medicine. To identify suitable pharmacokinetic marker(s) for indicating systemic exposure to Cardiotonic pills, we examined the in vivo pharmacokinetic properties of putatively active phenolic acids from the component herb Danshen (Radix Salviae Miltiorrhizae). We also performed in vitro and in silico assessments of permeability and solubility. Several phenolic acids were investigated, including: tanshinol, protocatechuic aldehyde, salvianolic acids A, B, and D, rosmarinic acid, and lithospermic acid. Plasma tanshinol exhibited the appropriate pharmacokinetic properties in dogs, including dose-dependent systemic exposure in area under concentration-time curve (AUC) and a 0.5-h elimination half-life. In rats, over 60% of intravenous tanshinol was excreted intact into the urine. In humans, we found a significant correlation between the urinary recovery of tanshinol and its plasma AUC. The absorption rate and bioavailability of tanshinol were not significantly different whether Cardiotonic pills were given orally or sublingually. The gender-specificity in plasma AUC disappeared after body-weight normalization, but the renal excretion of tanshinol was significantly greater in women than in men. Protocatechuic aldehyde was predicted to be highly permeable according to in vitro and in silico studies; however, extensive presystemic hepatic elimination and degradation in the erythrocytes led to extremely low plasma levels and poor dose proportionality. Integrated in vivo, in vitro, and in silico studies on the other phenolic acids showed poor gut permeability and nearly undetectable levels in plasma and urine. In conclusion, plasma and urinary tanshinol are promising pharmacokinetic markers for Cardiotonic pills at the tested dose levels.


Key words: absorption, drug disposition, excretion, gender differences, half-life, human pharmacokinetics, mass spectrometry, oral absorption, pharmacokinetics, renal elimination





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.